1 -(cyclopent-2-en-1 -yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

• 收藏
• 分享

专利权人:

GlaxoSmithKline Intellectual Property Development Limited

发明人:

Chen, Weichun,Igboko, Ebere F.,Lin, Xichen,Lu, Hongfu,Ren, Feng,Wren, Paul Bryan,Xu, Zhongmiao,Yang, Ting,Zhu, Lingdong

申请号：

AU2015265993

公开号：

AU2015265993A1

申请日:

2015.05.27

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/